Bimzelx (bimekizumab-bkzx) — Point32Health
Psoriatic arthritis
Preferred products
- Cimzia
- Enbrel
- Humira
- Simponi
- Skyrizi
- Yesintek
- Taltz
- Tremfya
- Rinvoq
- Xeljanz
Initial criteria
- Documented diagnosis of psoriatic arthritis
- Patient age ≥ 18 years
- Prescribed by or in consultation with a rheumatologist or dermatologist
- Documentation of one (1) of the following: a. Trial and failure with two (2), or contraindication to all of the following: Cimzia, Enbrel, Humira, Simponi, Skyrizi, Yesintek, Taltz, Tremfya, Rinvoq, Xeljanz OR b. The patient is new to the plan and stable on Bimzelx and the prescribing physician has documented that changing to a preferred product would result in adverse clinical outcomes